EU Clinical Trials Register

https://www.clinicaltrialsregister.eu/

Last activity: 05.05.2025

Active

Categories: Search

The EU Clinical Trials Register provides a free and accurate search of clinical trials in European Union member states and the European Economic Area.

Website visits

52K /mo.

Mentions

Mentions in press and media 33

Date	Title	Description
Sign up to see	Sign up to see	Sign up to see
May 5, 2025	OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab	OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab Lusvertikimab well tolerated over the 24-week additional treatment period. Oral presentation at DDW 2025 of cl...
Apr 29, 2025	Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb	No refractures were reported during long-term follow-up at five years At 24-months post-implantation, 89% of patients achieved bone union Novadip plans market launch of NVD003 in 2027 Mont Saint-Guibert, Belgium, April 29, 2025 – Novadip Bi...
Mar 14, 2025	Hansa Biopharma's Breakthrough in Kidney Transplantation: A New Hope for Highly Sensitized Patients	In the world of medicine, breakthroughs often feel like a distant star—visible, yet unreachable. However, Hansa Biopharma is changing that narrative for highly sensitized kidney transplant patients. The company recently announced the comple...
Mar 11, 2025	Hansa Biopharma completes enrolment in European Phase 3 20-HMedIdeS-19 Post Authorization Efficacy and Safety study in highly sensitized kidney transplant patients	Hansa Biopharma completes enrolment in European Phase 3 20-HMedIdeS-19 Post Authorization Efficacy and Safety study in highly sensitized kidney transplant patients Tue, Mar 11, 2025 14:35 CET Report this content Lund, Sweden, 11 March 2025....
Oct 17, 2024	Telix Q3 2024 Business Update - Quarterly Revenue Exceeds AU$200M	MELBOURNE, Australia, Oct. 17, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and operational performance for the quarter ended 30 September 2024 (Q3 2024). Revenue ...
Dec 20, 2023	Sedana Medical files submission for paediatric indication	Sedana Medical files submission for paediatric indication Wed, Dec 20, 2023 08:00 CET Report this content Sedana Medical AB (publ) announces that the company has submitted a Type II variation with the aim of including the paediatric populat...
Nov 16, 2023	Key results of Sedana Medical’s paediatric study IsoCOMFORT published	Key results of Sedana Medical’s paediatric study IsoCOMFORT published Thu, Nov 16, 2023 08:00 CET Report this content Sedana Medical AB (publ) today announces that the main results from the paediatric IsoCOMFORT study have been published in...
Jul 19, 2023	First patient treated with imlifidase in an investigator-initiated Phase 2 study in ANCA-associated vasculitis	First patient treated with imlifidase in an investigator-initiated Phase 2 study in ANCA-associated vasculitis Wed, Jul 19, 2023 08:00 CET Report this content Lund, Sweden 19 July, 2023. Hansa Biopharma (“Hansa”), a pioneer in enzyme techno...
Apr 18, 2023	Nordic Nanovector Publishes Data from the PARADIGME Phase 2 Clinical Trials with Betalutin® on European Clinical Trials Database	Nordic Nanovector Publishes Data from the PARADIGME Phase 2 Clinical Trials with Betalutin® on European Clinical Trials Database Tue, Apr 18, 2023 11:15 CET Report this content Oslo, Norway,18 April 2023 Nordic Nanovector ASA (OSE: NANOV) (...
Mar 29, 2023	Hansa Biopharma announces positive reimbursement decision in Spain for Idefirix[®] (imlifidase) as desensitization treatment for highly sensitized patients in kidney transplantation	Hansa Biopharma announces positive reimbursement decision in Spain for Idefirix[®] (imlifidase) as desensitization treatment for highly sensitized patients in kidney transplantation Wed, Mar 29, 2023 15:00 CET Report this content Lund, Swed...
Jul 11, 2022	Hansa Biopharma announces first patient treated in the post-authorization efficacy study (PAES) of Idefirix® (imlifidase) in highly sensitized kidney transplant patients	Hansa Biopharma announces first patient treated in the post-authorization efficacy study (PAES) of Idefirix® (imlifidase) in highly sensitized kidney transplant patients Mon, Jul 11, 2022 08:00 CET Report this content The PAES is an open-la...
Mar 14, 2022	Update on US review of Fasenra in nasal polyps	Update on US review of Fasenra in nasal polyps Mon, Mar 14, 2022 08:00 CET Report this content 14 March 2022 07:00 GMT Update on US regulatory review of Fasenra in chronic rhinosinusitis with nasal polyps The US Food and Drug Administration...
Feb 11, 2022	EMA initiates safety review on JAK inhibitors; Galapagos woes continue as it terminates latest study	Following the FDA’s issuance of a safety warning regarding JAK inhibitors, the safety committee of the European Medicines Agency on Friday initiated a review of these treatments, which are used to treat several chron...
Feb 10, 2022	BioGaia Pharma announces First Patient Enrolled in Phase I Clinical Study Evaluating BGP014 in mild to moderate ulcerative colitis (AUCH-1).	BioGaia Pharma received formal approval from relevant authorities to proceed with both of its planned clinical trials during summer 2021. Investigational Medical Products were delivered to sites Q4 2021 and screening began. The first patien...
Feb 10, 2022	BioGaia Pharma announces First Patient Enrolled in Phase I Clinical Study Evaluating BGP014 in mild to moderate ulcerative colitis (AUCH-1).	BioGaia Pharma announces First Patient Enrolled in Phase I Clinical Study Evaluating BGP014 in mild to moderate ulcerative colitis (AUCH-1). Thu, Feb 10, 2022 09:30 CET Report this content BioGaia Pharma received formal approval from releva...
Jan 26, 2022	BioGaia Pharma announces First Patient Enrolled in Phase II Clinical Study Evaluating BGP345A for the treatment of opioid induced constipation (OIC-1)	BioGaia Pharma announces First Patient Enrolled in Phase II Clinical Study Evaluating BGP345A for the treatment of opioid induced constipation (OIC-1) Wed, Jan 26, 2022 09:30 CET BioGaia Pharma received formal approval from relevant authori...
Jan 26, 2022	BioGaia Pharma announces First Patient Enrolled in Phase II Clinical Study Evaluating BGP345A for the treatment of opioid induced constipation (OIC-1)	BioGaia Pharma received formal approval from relevant authorities to proceed with both of its planned clinical trials during summer 2021. Investigational Medical Products were delivered to sites Q4 2021 and screening began. The first patien...
Dec 8, 2021	Last-gasp gene therapy saved a Syrian refugee’s life. Five years later, the boy is thriving and a clinical trial is starting	In the summer of 2015, a 7-year-old named Hassan was admitted to the burn unit of the Ruhr University Children’s Hospital in Bochum, Germany, with red, oozing wounds from head to toe. It wasn’t a fire that took his skin. It was a bacterial ...
Sep 10, 2021	BioGaia : Pharma secures approval for two clinical trials for its pharmaceutical candidates	BioGaia Pharma has received formal approval from relevant authorities to proceed with both of its planned clinical trials. The trials are the next phase in the development of BioGaia Pharma's two pharmaceutical product candidates. The biolo...
Sep 10, 2021	BioGaia Pharma secures approval for two clinical trials for its pharmaceutical candidates	BioGaia Pharma secures approval for two clinical trials for its pharmaceutical candidates Fri, Sep 10, 2021 10:00 CET BioGaia Pharma has received formal approval from relevant authorities to proceed with both of its planned clinical trials....
Jul 4, 2021	Regulators in many European countries fail to ensure clinical trial data are available	Amid ongoing concerns over clinical trial transparency, a new report finds “notable gaps” in the quality and availability of clinical trial data in a European registry, pointing to inconsistent and often inadequate oversight by regulators i...
Apr 14, 2021	Novel COVID-19 therapy enters phase 2 clinical trials
Apr 14, 2021	Novel COVID-19 therapy enters phase 2 clinical trials	Kinarus AG is a clinical-stage biopharmaceutical company focused on bringing novel treatments to patients suffering from viral, respiratory, and ophthalmic diseases. The company's unique and innovative combinatorial therapeutic candidate KI...
Oct 21, 2020	The MOTIVATE US webinar series is about to start
May 9, 2020	A Coronavirus Vaccine is Coming, but When?	wp_booster error: td_api_base::get_key : a component with the ID: single_template_6 Key: show_featured_image_on_all_pages is not set. /var/web/site/public_html/wp-content/plugins/td-composer/legacy/common/wp_booster/td_api.php (rara-error) ...
May 9, 2020	A Coronavirus Vaccine is Coming, but When?	wp_booster error: td_api_base::get_key : a component with the ID: single_template_6 Key: show_featured_image_on_all_pages is not set. /home/r8qkakm4wchc/public_html/wp-content/plugins/td-composer/legacy/common/wp_booster/td_api.php (rara-er...
Apr 14, 2020	Central, Searchable Repository for all COVID-19 Clinical Trials Launches	What You Need to Know: – Inato unveils central, searchable repository for all COVID-19 clinical trials designed to support clinical researchers, physicians, and biopharma organizations. – By centralizing all clinical studies being conducted...
Aug 21, 2018	FDA accepts Alexion’s application for next-generation PNH drug	ALXN1210 is a long-acting medicine with the same target as Soliris (eculizumab), for which Alexion won FDA approval for reducing red blood cell destruction – also known as hemolysis – in PNH in 2007, but which must be dosed more frequently....
Nov 3, 2016	What clinical trial results? Now you can see who isn’t sharing their findings	The results for nearly half of all clinical trials conducted by big drug makers during the last decade have not been published, and one company — Ranbaxy Laboratories — has not published findings for any of the nearly three dozen trials con...
Jan 20, 2016	French debacle renews concern about clinical trial secrecy Clinical trial reporting lapses visualized	The death of a volunteer in a calamitous drug trial in France last week renewed concerns about the safety of early-stage human testing and the lack of a comprehensive public database that tracks the outcomes of such clinical trials. The vic...
Feb 20, 2014	Raising the veil on clinical trial data	By Tom Ulrich Ed. note: This is the first in a two- part series on making clinical trial data more transparent. 2013 was the year when big data became, well, big. Everyone from investment companies to public utilities to security agencies –...
	FDA accepts Alexion’s application for next-generation PNH drug	The Food and Drug Administration has accepted for priority review Alexion Pharmaceuticals’ new drug for a rare blood disorder. The New Haven, Connecticut-based company said Monday that the FDA would review its application for ALXN1210, a C5...

Reviews 0

FAQ about EU Clinical Trials Register

What has the press written about EU Clinical Trials Register?

Parsers VC has collected 33 articles mentioning EU Clinical Trials Register, among them “OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab” (May 5, 2025) and “Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb” (Apr 29, 2025).

Is EU Clinical Trials Register still active?

Yes, EU Clinical Trials Register is active; its latest activity on Parsers VC dates from May 5, 2025.